Sage Journals: Discover world-class research

Free access

Research article

First published 2010-11

Gastroenteropancreatic Neuroendocrine Tumors: Standardizing Therapy Monitoring with 68 Ga-DOTATOC PET/CT Using the Example of Somatostatin Receptor Radionuclide Therapy

Wolfgang Luboldt, Holger Hartmann, Bärbel Wiedemann [...]

Molecular Imaging

Retricted access

Research article

First published 2021-10

Potential for Increasing Uptake of Radiolabeled 68 Ga-DOTATOC and 123 I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat

Janet H. Pollard, Yusuf Menda, K.D. Zamba [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2009-04

Relative Quantification of Indium-111 Pentetreotide and Gallium-68 DOTATOC Uptake in the Thyroid Gland and Association with Thyroid Pathologies

Thomas Lincke, Joerg Singer, Regine Kluge [...]

Thyroid®

Retricted access

Research article

First published 2014-04

Differentiated Thyroid Cancer: A New Perspective with Radiolabeled Somatostatin Analogues for Imaging and Treatment of Patients

Annibale Versari, Martina Sollini, Andrea Frasoldati [...]

Thyroid®

Retricted access

Research article

First published 2014-04

Gallium-68 DOTATOC PET/CT In Vivo Characterization of Somatostatin Receptor Expression in the Prostate

Mila V. Todorović-Tirnanić, Milan M. Gajić, Vladimir B. Obradović [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Case report

First published 2019-6

Intrapancreatic accessory spleen mimicking malignant tumor: three case reports

Maria Zurek Munk-Madsen, Kristine Zakarian, Peter Sandor Oturai [...]

Acta Radiologica Open

Retricted access

Research article

First published 2021-06

First Ex Vivo Results of β − -Radioguided Surgery in Small Intestine Neuroendocrine Tumors with 90 Y-DOTATOC

Emilio Bertani, Francesco Collamati, Marzia Colandrea [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results

Gastroenteropancreatic Neuroendocrine Tumors: Standardizing Therapy Monitoring with 68 Ga-DOTATOC PET/CT Using the Example of Somatostatin Receptor Radionuclide Therapy

Potential for Increasing Uptake of Radiolabeled 68 Ga-DOTATOC and 123 I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat

Relative Quantification of Indium-111 Pentetreotide and Gallium-68 DOTATOC Uptake in the Thyroid Gland and Association with Thyroid Pathologies

Differentiated Thyroid Cancer: A New Perspective with Radiolabeled Somatostatin Analogues for Imaging and Treatment of Patients

Gallium-68 DOTATOC PET/CT In Vivo Characterization of Somatostatin Receptor Expression in the Prostate

Intrapancreatic accessory spleen mimicking malignant tumor: three case reports

First Ex Vivo Results of β − -Radioguided Surgery in Small Intestine Neuroendocrine Tumors with 90 Y-DOTATOC